Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Kahr Medical
Amgen
Eli Lilly and Company
Novartis
Takeda
Guangzhou Lupeng Pharmaceutical Company LTD.
Prelude Therapeutics
Nanexa AB
Biocity Biopharmaceutics Co., Ltd.
University of California, Davis
Jonsson Comprehensive Cancer Center
Celgene
Mayo Clinic
National Cancer Institute (NCI)
Boehringer Ingelheim
Celgene
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins